Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Selling, General & Administrative of $25.92 million for Q2 2026, down 9.0% from $28.48 million a year earlier.
Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Karyopharm Therapeutics was $103.77 million, down 6.2% year-over-year; for FY2025, it was $105.21 million, down 8.9% from FY2024.
- Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Selling, General & Administrative was $115.44 million in FY2024 (-12.5%), $131.88 million in FY2023 (-9.3%), $145.4 million in FY2022 (+1.1%) and $143.85 million in FY2021 (+13.8%).
- Quarterly Selling, General & Administrative has run from a low of $22.77 million in Q4 2025 to a high of $38.77 million in Q1 2022 over five years.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 13.4%; the weakest was Q1 2024, with a decline of 17.7%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Karyopharm Therapeutics | 23.15 Mn | -203.27 Mn | 32.35 Mn | 25.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.92 Mn |
| Dec 31, 2025 | 22.77 Mn |
| Sep 30, 2025 | 26.61 Mn |
| Jun 30, 2025 | 28.48 Mn |
| Mar 31, 2025 | 27.35 Mn |
| Dec 31, 2024 | 27.19 Mn |
| Sep 30, 2024 | 27.63 Mn |
| Jun 30, 2024 | 31.07 Mn |
| Mar 31, 2024 | 29.55 Mn |
| Dec 31, 2023 | 30.69 Mn |
| Sep 30, 2023 | 30.81 Mn |
| Jun 30, 2023 | 34.48 Mn |
| Mar 31, 2023 | 35.91 Mn |
| Dec 31, 2022 | 34.65 Mn |
| Sep 30, 2022 | 34.65 Mn |
| Jun 30, 2022 | 37.34 Mn |
| Mar 31, 2022 | 38.77 Mn |
| Dec 31, 2021 | 34.56 Mn |
| Sep 30, 2021 | 35.10 Mn |
| Jun 30, 2021 | 36.53 Mn |
Karyopharm Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KPTI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();